VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
HNGEHinge Health, Inc.$65.34$5.1B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHNGEEarnings History

HNGE logoHinge Health, Inc. (HNGE) Earnings History

Net Loss

3 years of earnings data (2023–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$510M
● Net Loss
TTM EPS (Diluted)
$-6.19
Per share, diluted
YoY EPS Growth
-3360.0%
Declining
Net Margin
-89.9%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin-92.9%
Gross Margin79.6%
Return on Equity-132.9%
Return on Assets-74.5%
Record Annual Net Income-$12MFY2024
Record Quarterly EPS$1.55Q1 2025
Consecutive Profitable Years0years
Q1 2026
Net Income$35M
EPS (Diluted)$0.41
YoY Growth-3360.0%Declining
QoQ Growth+9.5%Solid

Loading earnings history...

Hinge Health, Inc. (HNGE) Earnings Overview

As of June 13, 2026, Hinge Health, Inc. (HNGE) reported trailing twelve-month net income of -$510M, reflecting -3360.0% year-over-year growth. The company earned $-6.19 per diluted share over the past four quarters, with a net profit margin of -89.9%.

Looking at the long-term picture, HNGE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$12M in fiscal 2024.

Hinge Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including OMCL ($20M net income, 0.2% margin), TDOC (-$171M net income, -7.9% margin), HIMS (-$13M net income, 5.5% margin), HNGE has room to improve margins relative to the peer group. Compare HNGE vs OMCL →

HNGE Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
HNGE logoHNGECurrent
-$510M$-6.19-89.9%-132.9%-3360.0%—
OMCL logoOMCL
$20M$0.440.2%0.2%-83.6%
TDOC logoTDOC
-$171M$-0.96-7.9%-13.9%+80.6%
HIMS logoHIMS
-$13M$-0.065.5%25.2%-3.8%
DOCS logoDOCS
$196M$1.0130.4%19.3%-11.7%
AMWL logoAMWL
-$88M$-5.30-38.4%-33.9%+57.1%
Best in group
Lowest in group

HNGE Historical Earnings Data (2023–2025)

3 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$528M-4326.9%-$546M$-5.19-89.9%-92.9%
2024-$12M+89.0%-$24M$-0.15-3.1%-6.3%
2023-$108M--$131M$-1.39-36.9%-44.6%

Download Data

Export HNGE earnings history in CSV or JSON format

Free sign-in required to download data

What if you invested $1,000 in HNGE back in 2023?

Total return with dividends reinvested · 3+ years of data

Calculate Returns

How much would $100/month in HNGE be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is HNGE Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

HNGE vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

HNGE — Frequently Asked Questions

Quick answers to the most common questions about buying HNGE stock.

What is HNGE earnings per share (EPS)?

HNGE trailing twelve-month (TTM) diluted EPS is $-6.19, reflecting -3360.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2023 to 2025 is available in the table on this page.

What is Hinge Health, Inc.'s net income?

Hinge Health, Inc. (HNGE) trailing twelve-month net income is $-510M as of 2025. Earnings declined -3360.0% year-over-year.

Is HNGE profitable?

HNGE is not currently profitable on a TTM basis, reporting a net loss of $-510M. Net margin is -89.9%. Investors should monitor for a return to profitability.

What is HNGE's earnings growth rate?

HNGE compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2023 to 2025.

What are HNGE's profit margins?

Hinge Health, Inc. net profit margin is -89.9%, operating margin is -92.9%, and gross margin is +79.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is -132.9%.

Is HNGE growing earnings?

HNGE earnings are declining — EPS fell -3360.0% year-over-year. TTM net income dropped to $-510M. This contrasts with the 5-year CAGR of N/A.

What was HNGE's best earnings year?

Hinge Health, Inc.'s highest annual net income on record is $-12M, achieved in fiscal year 2024. Earnings history on this page spans 2023 to 2025 and includes all annual and quarterly figures.

What were HNGE's earnings last quarter?

HNGE's most recent reported quarter was Q1 2026. Net income was $35M with diluted EPS of $0.41. For a full breakdown of all quarters, see the quarterly earnings table on this page.

HNGE Earnings Over Time (2023–2025)

Net income & EPS — annual and quarterly view